ReviewThe American journal of medicine2022

Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.

Philip C Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.